Patents by Inventor Jack V. D. Hough
Jack V. D. Hough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8303990Abstract: Diagnosing or treating a human ear includes transporting a conjugated nanoparticle or a magnetically responsive nanoparticle into a human's middle or inner ear. Otologic nanophoresis includes electrically, magnetically or electromagnetically driving a nanoparticle through a membrane of the ear, including a tympanic membrane, a round window membrane, an oval window membrane, or a circulatory membrane. An otologic diagnostic device includes a nanoparticle conjugated with a material selected from the group consisting of lipids, proteins, growth factors, growth hormones, antioxidants, free radical scavengers, steroid preparations, and metabolically active substances; an otologic therapeutic device includes the same categories of substances and chemotherapeutic drugs. Another otologic composition includes a nanoparticle conjugated with a substance perceptible to magnetic resonance imaging.Type: GrantFiled: April 22, 2008Date of Patent: November 6, 2012Assignee: Hough Ear InstituteInventors: R. Kent Dyer, Jr., Jack V. D. Hough
-
Publication number: 20080199400Abstract: Diagnosing or treating a human ear includes transporting a conjugated nanoparticle or a magnetically responsive nanoparticle into a human's middle or inner ear. Otologic nanophoresis includes electrically, magnetically or electromagnetically driving a nanoparticle through a membrane of the ear, including a tympanic membrane, a round window membrane, an oval window membrane, or a circulatory membrane. An otologic diagnostic device includes a nanoparticle conjugated with a material selected from the group consisting of lipids, proteins, growth factors, growth hormones, antioxidants, free radical scavengers, steroid preparations, and metabolically active substances; an otologic therapeutic device includes the same categories of substances and chemotherapeutic drugs. Another otologic composition includes a nanoparticle conjugated with a substance perceptible to magnetic resonance imaging.Type: ApplicationFiled: April 22, 2008Publication date: August 21, 2008Inventors: R. Kent Dyer, Jack V.D. Hough
-
Publication number: 20040133099Abstract: Diagnosing or treating a human ear includes transporting a conjugated nanoparticle or a magnetically responsive nanoparticle into a human's middle or inner ear. Otologic nanophoresis includes electrically, magnetically or electromagnetically driving a nanoparticle through a membrane of the ear, including a tympanic membrane, a round window membrane, an oval window membrane, or a circulatory membrane. An otologic diagnostic device includes a nanoparticle conjugated with a material selected from the group consisting of lipids, proteins, growth factors, growth hormones, antioxidants, free radical scavengers, steroid preparations, and metabolically active substances; an otologic therapeutic device includes the same categories of substances and chemotherapeutic drugs. Another otologic composition includes a nanoparticle conjugated with a substance perceptible to magnetic resonance imaging.Type: ApplicationFiled: December 17, 2003Publication date: July 8, 2004Inventors: R. Kent Dyer, Jack V.D. Hough
-
Patent number: 5015225Abstract: An implantable electromagnetic middle-ear bone-conduction hearing aid device is provided which is characterized by being carried entirely in the skull of the user, the absence of electrodes entering the middle-ear, and variability to meet a variety of pathological entities of the hearing impaired user. The device utilizes a sound processing component adapted to be positioned in the skull of the user and to extend from close proximity to the outside of the skull toward and within close proximity to the middle-ear of the user for receiving and converting sound into an electromagnetic signal and for transmitting the electromagnetic signal into the middle-ear of the user.Type: GrantFiled: March 17, 1988Date of Patent: May 14, 1991Assignee: Xomed, Inc.Inventors: Jack V. D. Hough, Kenneth J. Dormer, Kenneth E. Barton, Jr., Robert Y. Chow
-
Patent number: 4776322Abstract: An implantable electromagnetic middle-ear bone-conduction hearing aid device is provided which is characterized by being carried entirely in the skull of the user, the absense of electrodes entering the middle-ear, and variability to meet a variety of pathological entities of the hearing impaired user. The device utilizes a sound processing component adapted to be positioned in the skull of the user and to extend from close proximity to the outside of the skull toward and within close proximity to the middle-ear of the user for receiving and converting sound into an electromagnetic signal and for transmitting the electromagnetic signal into the middle-ear of the user.Type: GrantFiled: August 18, 1986Date of Patent: October 11, 1988Assignee: Xomed, Inc.Inventors: Jack V. D. Hough, Kenneth J. Dormer, Kenneth E. Barton, Jr., Robert Y. Chow
-
Patent number: 4774933Abstract: A bone conduction hearing device in the form of a magnetic disk is implanted and fastened to the temporal bone by a screw thread connection. Apparatus includes instruments for accurately drilling and tapping a hole in the temporal bone, and a wrench for tightening the magnetic disk hearing device against the bone.Type: GrantFiled: November 17, 1987Date of Patent: October 4, 1988Assignee: Xomed, Inc.Inventors: Jack V. D. Hough, Paul DiCarlo
-
Patent number: 4612915Abstract: A direct bone conduction hearing aid device is disclosed and includes a sound processor for receiving sound and generating an amplified electromagnetic signal in response thereto. This signal is transmitted to a subcutaneously implanted vibration generating means which is secured to a skull bone of the user and which includes magnetic means. An analog signal causes the magnet to vibrate and these vibrations are transmitted to the skull bone and thence to the cochlea to create the perception of sound.Type: GrantFiled: May 23, 1985Date of Patent: September 23, 1986Assignee: Xomed, Inc.Inventors: Jack V. D. Hough, Gordon L. Richard, Kenneth E. Barton, Jr., Paul DiCarlo, Robert Y. Chow
-
Patent number: 4606329Abstract: An implantable electromagnetic middle-ear bone conduction hearing aid device is disclosed which provides variability to meet a variety of pathological entities of the hearing impaired user. The device utilizes a sound processing component for converting sound into an analog electromagnetic signal and has an output transmitter adapted to be placed supercutaneously on the skull of the user for transmitting the electromagnetic signal transcutaneously. A signal receiving and transmitting component is adapted to be implanted subcutaneously in the bone of the user outside of the middle ear for receiving the transcutaneous electromagnetic signal from the sound processing component and for transmitting the electromagnetic signal subcutaneously into the middle-ear of the user.Type: GrantFiled: June 17, 1985Date of Patent: August 19, 1986Assignee: Xomed, Inc.Inventor: Jack V. D. Hough
-
Patent number: RE46373Abstract: Diagnosing or treating a human ear includes transporting a conjugated nanoparticle or a magnetically responsive nanoparticle into a human's middle or inner ear. Otologic nanophoresis includes electrically, magnetically or electromagnetically driving a nanoparticle through a membrane of the ear, including a tympanic membrane, a round window membrane, an oval window membrane, or a circulatory membrane. An otologic diagnostic device includes a nanoparticle conjugated with a material selected from the group consisting of lipids, proteins, growth factors, growth hormones, antioxidants, free radical scavengers, steroid preparations, and metabolically active substances; an otologic therapeutic device includes the same categories of substances and chemotherapeutic drugs. Another otologic composition includes a nanoparticle conjugated with a substance perceptible to magnetic resonance imaging.Type: GrantFiled: November 5, 2014Date of Patent: April 25, 2017Assignee: HOUGH EAR INSTITUTEInventors: R. Kent Dyer, Jr., Jack V. D. Hough
-
Patent number: RE47849Abstract: Diagnosing or treating a human ear includes transporting a conjugated nanoparticle or a magnetically responsive nanoparticle into a human's middle or inner ear. Otologic nanophoresis includes electrically, magnetically or electromagnetically driving a nanoparticle through a membrane of the ear, including a tympanic membrane, a round window membrane, an oval window membrane, or a circulatory membrane. An otologic diagnostic device includes a nanoparticle conjugated with a material selected from the group consisting of lipids, proteins, growth factors, growth hormones, antioxidants, free radical scavengers, steroid preparations, and metabolically active substances; an otologic therapeutic device includes the same categories of substances and chemotherapeutic drugs. Another otologic composition includes a nanoparticle conjugated with a substance perceptible to magnetic resonance imaging.Type: GrantFiled: April 21, 2017Date of Patent: February 11, 2020Assignee: HOUGH EAR INSTITUTEInventors: R. Kent Dyer, Jr., Jack V. D. Hough